Skip to main content

Table 2 Non-susceptibility a rates (%) for the total isolate yield of the study (n = 563)

From: Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

Antimicrobial agent Escherichia coli (n = 330) Klebsiella spp (n = 91) Proteus mirabilis (n = 142)
Amoxicillin 31.5 N/A b 33.1
Amoxicillin/clavulanic acid 6.4 1.1 4.2
Cefalothin 9.1 3.3 13.4
Cefuroxime sodium 2.7 1.1 1.4
Cefuroxime axetil 3.9 3.3 2.8
Co-trimoxazole 23.6 11.0 13.4
Nalidixic acid 8.2 9.9 5.6
Ciprofloxacin 4.8 5.5 1.4
Mecillinam 3.6 1.1 22.5
Nitrofurantoin 6.4 30.8 N/A b
Fosfomycin c 1.2 1.1 9.9
Cefotaxime 3.0 1.1 1.4
Ceftazidime 0.6 1.1 3.5
Gentamicin 2.1 1.1 4.2
Netilimicin 0.6 1.1 0.7
Amikacin 0.9 1.1 0
Piperacillin-tazobactam 0.6 1.1 0
Ticarcillin-clavulanate 0.9 1.1 0.7
Imipenem 0.6 0 0.7
Cefditoren 3.0 3.3 2.1
  1. a CLSI 2011 breakpoints of susceptibility were applied.
  2. b N/A: not applicable (species inherently resistant).
  3. c Fosfomycin trometamol is no long marketed in Greece.